An Early Phase Trial of RPTR-1-201 in Advanced Solid Tumors

by | Dec 29, 2025 | Clinical Trials | 0 comments

​ Conditions: Advanced Malignant Solid Tumor

Interventions: Drug: RPTR-1-201; Drug: PD-1 / PD-L1 monoclonal antibody

Sponsors: Repertoire Immune Medicines

Not yet recruiting Conditions: Advanced Malignant Solid Tumor
Interventions: Drug: RPTR-1-201; Drug: PD-1 / PD-L1 monoclonal antibody
Sponsors: Repertoire Immune Medicines
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *